[1]
|
C. H. Gonzalez, F. Vargas, A. B. Perez, C. A. Kim, D. Brunoni, M. J. Marques-Dias, C. R. Leone, J. Correa Neto, J. C. Llerena Junior and J. C. de Almeida, “Limb Deficiency with or without Moebius Sequence in Seven Brazilian Children Associated with Misoprostol Use in the First Trimester of Pregnancy,” American Journal of Medical Genetics, Vol. 47, No. 1, 1993, pp. 59-64.
doi:10.1002/ajmg.1320470113
|
[2]
|
K. Blanchard, B. Winikoff and C. Ellertson, “Use of Misoprostol during Pregnancy and Mobius’ Syndrome in Infants,” The New England Journal of Medicine, Vol. 339, No. 21, 1998, pp. 1553-1554.
doi:10.1056/NEJM199811193392114
|
[3]
|
L. Schüller, A. Pastuszak, M. T. Sanseverino, I. M. Orioli, D. Brunoni and G. Koren, “Pregnancy Outcome after Abortion Attempt with Misoprostol,” Teratology, Vol. 55, No. 36, 1997, pp. 1-28.
|
[4]
|
F. R. Vargas, L. Schuler-Faccini, D. Brunoni, C. Kim, V. F. Meloni, S. M. Sugayama, L. Albano, J. C. Llerena, J. C. Almeida, A. Duarte, D. P. Cavalcanti Jr., E. Goloni-Bertollo, A. Conte, G. Koren and A. Addis, “Prenatal Exposure to Misoprostol and Vascular Disruption Defects: A Case-Control Study,” American Journal of Medical Genetics, Vol. 95, No. 4, 2000, pp. 302-306.
doi:10.1002/1096-8628(20001211)95:4<302::AID-AJMG2>3.0.CO;2-B
|
[5]
|
F. S. Collins and M. Mahoney, “Hydrocephalus and Abnormal Digits after First-Trimester Prostaglandin Abortion Attempt,” Journal of Pediatrics, Vol. 102, No. 4, 1983, pp. 620-621. doi:10.1016/S0022-3476(83)80204-2
|
[6]
|
M. Wheeler, P. O’Meara and M. Stanford, “Fetal Methotrexate and Misoprostol Exposure: The Past Revisited,” Teratology, Vol. 66, No. 2, 2002, pp. 73-76.
doi:10.1002/tera.10052
|
[7]
|
A. L. Pastuszak, L. Schüler, C. E. Speck-Martins, K. E. Coelho, S. M. Cordello, F. Vargas, D. Brunoni, I. V. Schwarz, M. Larrandaburu, H. Safattle, V. F. Meloni and G. Koren, “Use of Misoprostol during Pregnancy and Mobius’ Syndrome in Infants,” The New England Journal of Medicine, Vol. 338, No. 26, 1998, pp. 1881-1885.
doi:10.1056/NEJM199806253382604
|
[8]
|
T. H. Shepard, “Mobius Syndrome after Misoprostol a Possible Teratogenic Mechanism,” Lancet, Vol. 346, No. 8977, 1995, p. 780. doi:10.1016/S0140-6736(95)91540-0
|
[9]
|
K. E. Coelho, M. F. Sarmento, C. M. Veiga, C. E. SpeckMartins, H. P. Safatle, C. V. Castro and N. Niikawa, “Misoprostol Embryotoxicity: Clinical Evaluation of Fifteen Patients with Arthrogryposis,” American Journal of Medical Genetics, Vol. 95, No. 4, 2000, pp. 297-301.
doi:10.1002/1096-8628(20001211)95:4<297::AID-AJMG1>3.0.CO;2-K
|
[10]
|
C. H. Gonzalez, M. J. Marques-Dias, C. A. Kim, S. M. Sugayama, J. A. Da Paz, S. M. Huson and L. B. Holmes, “Congenital Abnormalities in Brazilian Children Associated with Misoprostol Misuse in First Trimester of Pregnancy,” Lancet, Vol. 351, No. 9116, 1998, pp. 16241627. doi;10.1016/S0140-6736(97)12363-7
|